Rajesh Kumar Dutta - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Rajesh Kumar Dutta

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Communications Medicine|June 11, 2026

A unimolecular GLP-1 and FGF21 dual agonist for treatment of metabolic dysfunction-associated steatohepatitisParul Sirohi, Seh-Hoon Oh, Catherine G Price, et al.

The Journal of Clinical Investigation|August 27, 2024

The senescence-associated secretome of Hedgehog-deficient hepatocytes drives MASLD progressionJi Hye Jun, Kuo Du, Rajesh Kumar Dutta, et al.

Hepatology (Baltimore, Md.)|February 23, 2023

Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosisKuo Du, Raquel Maeso-Díaz, Seh Hoon Oh, et al.

Nature Communications|September 10, 2025

Dysregulated RNA splicing impairs regeneration in alcohol-associated liver diseaseUllas V Chembazhi, Sushant Bangru, Rajesh Kumar Dutta, et al.

Journal of Hepatology|May 8, 2021

Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver diseaseJeongeun Hyun, Muthana Al Abo, Rajesh Kumar Dutta, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Communications Medicine|June 11, 2026

A unimolecular GLP-1 and FGF21 dual agonist for treatment of metabolic dysfunction-associated steatohepatitisParul Sirohi, Seh-Hoon Oh, Catherine G Price, et al.

The Journal of Clinical Investigation|August 27, 2024

The senescence-associated secretome of Hedgehog-deficient hepatocytes drives MASLD progressionJi Hye Jun, Kuo Du, Rajesh Kumar Dutta, et al.

Hepatology (Baltimore, Md.)|February 23, 2023

Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosisKuo Du, Raquel Maeso-Díaz, Seh Hoon Oh, et al.

Nature Communications|September 10, 2025

Dysregulated RNA splicing impairs regeneration in alcohol-associated liver diseaseUllas V Chembazhi, Sushant Bangru, Rajesh Kumar Dutta, et al.

Journal of Hepatology|May 8, 2021

Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver diseaseJeongeun Hyun, Muthana Al Abo, Rajesh Kumar Dutta, et al.

Pageof 2